These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3072419)

  • 1. Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension.
    Beretta-Piccoli C; Salvadé G; Bachmann C; Riesen W; Zuppinger K
    J Hum Hypertens; 1988 Aug; 2(2):103-10. PubMed ID: 3072419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin in the treatment of diabetes-associated hypertension.
    Beretta-Piccoli C
    Drugs; 1988; 36 Suppl 1():35-43. PubMed ID: 3071461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
    Pollare T; Lithell H; Berne C
    N Engl J Med; 1989 Sep; 321(13):868-73. PubMed ID: 2671740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus.
    Fogari R; Zoppi A; Pasotti C; Nicrosini S; Lazzari P; Corradi L
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):218-22. PubMed ID: 2365539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antihypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement.
    McCormack PM; Cox JP; Marron J; Mee F; Atkins N; O'Brien E; O'Malley K
    J Hum Hypertens; 1990 Oct; 4(5):565-70. PubMed ID: 2283647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and metabolic effects of nitrendipine in hypertensive diabetic patients.
    Giuntoli F; Galeone F; Gabbani S; Spagnolo G; Brunelleschi G; Natali A; Gallo Stampino C; Saba P
    Clin Ther; 1990; 12(5):421-6. PubMed ID: 2268864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional haemodynamics and antihypertensive effects during long-term ketanserin treatment.
    Persson B; Petterson A; Andersson O; Berglund G; Hedner T
    J Hypertens Suppl; 1986 Apr; 4(1):S99-101. PubMed ID: 2939223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL; Hanson C; Lucas C; Rosenblatt S; Rosenstock J; Whittier F; Wistran D; Riche C; Mulcahy WS
    Clin Ther; 1993; 15(1):79-87. PubMed ID: 8458057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
    Hosie J; Stott DJ; Robertson JI; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
    Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.